Day: October 25, 2019

INTERIM FINANCIAL REPORT JANUARY -SEPTEMBER 2019

Written by Customer Service on October 25, 2019. Posted in Public Companies.

WESTPAY MAINTAINS ITS REVENUE GROWTH TREND AND PARTNERS CONTINUE TO RESPOND IN A POSITIVE WAYTHIRD QUARTER 2019Net sales totalled MSEK 15.5 (11.7), an increase of MSEK 3.8 / 32 %EBITDA was MSEK -3.1 (-5.4), an improvement with MSEK 2.2Operating profit/loss was MSEK -4.9 (-6.7), an improvement with MSEK 1.8Profit/loss after tax was MSEK -4.2 (-5.6), an improvement with MSEK 1.3Net earnings per share amounted to SEK -0.19 (-0.25)JANUARY – SEPTEMBER 2019Net sales totalled MSEK 43.8 (56.0), a decrease with MSEK 12.2 / -22 %EBITDA was MSEK -11.4 (-2.1), a decrease with MSEK 9.3Operating profit/loss was MSEK -16.1 (-6.1), a decrease with MSEK 9.9Profit/loss after tax was MSEK -13.3 (-5.3), a decrease with MSEK 8.0Net earnings per share amounted to SEK -0.59 (-0.24) SIGNIFICANT EVENTS DURING THE QUARTERNew long-term agreement with Open, minimum...

ICONOVO AB (PUBL) MAKES A SIGNIFICANT INVESTMENT IN THE DEVELOPMENT OF A NEW INHALATION PLATFORM

Written by Customer Service on October 25, 2019. Posted in Public Companies.

Iconovo AB (publ) announced today that the company has made a decision to invest in the development of a new dry powder inhalation platform. This platform will comprise a new inhalation device, ICOpre, and bespoke dry powder formulations. The new products are developed to target the global market including the US.In the coming ten years, the inhalation market is expected to be dominated by the GlaxoSmithKline products based on the new Ellipta inhalation device. At present, five drug products are available in Ellipta with a total market value of 2.7 BUSD (2018). The value is expected to grow to 5.0 BUSD in 2024 (source: Evaluate Pharma Vantage publications). The first patent protecting these products will expire starting 2025 and Iconovo is investing to be able to offer generic versions of these products. Iconovo’s estimates of the business...

ICONOVO AB (PUBL) STORSATSAR PÅ UTVECKLING AV EN NY INHALATIONSPLATTFORM

Written by Customer Service on October 25, 2019. Posted in Public Companies.

Inhalationsutvecklaren Iconovo AB (publ) tillkännager i dag att bolaget har tagit ett strategiskt beslut att investera i utveckling av en ny inhalationsplattform. Denna består av en ny inhalator vid namn ICOpre samt nya torrpulverformulering anpassade till ICOpre. Den nya plattformen är avsedd för en global marknad inklusive USA.Under de närmaste 10 åren förväntas inhalationsmarknaden domineras av produkter i GlaxoSmithKlines nya inhalator Ellipta. Det finns för närvarande fem produkter i Ellipta med ett försäljningsvärde 2018 på nästan 2.7 miljarder USD. Det värdet väntas öka till 5.0 miljarder USD år 2024 (Källa: Evaluate Pharma Vantage publications). De första patenten på dessa produkter kommer att falla 2025 och Iconovo investerar för att kunna erbjuda generiska versioner. Iconovo´s värdering av affärsmöjligheten som ligger till grund...

Adevinta ASA (ADE) – Ex. Preferential rights for holders of class A shares today in the Rights Issue, first day of trading in ordinary shares after combination of share classes and change of ISIN

Written by Customer Service on October 25, 2019. Posted in Public Companies.

25 October 2019, OsloReference is made to the stock exchange announcement of Adevinta ASA (the “Company”) on 24 October 2019.The shares in Adevinta ASA will be traded ex preferential rights for holders of A shares in the rights issue as of today, 25 October 2019.Further, as of today, Adevinta ASA’s shares are traded under ISIN 0010844038 and ticker “ADE”.This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.About Adevinta ASA:Adevinta ASA is the biggest marketplace specialist in Europe. We help our local digital marketplaces thrive through global connections and networks of knowledge. Our marketplaces unlock the full value in every person, place and thing – helping local communities prosper and leaving a positive footprint on the world.For...

Nilörngruppen AB: Interim Q3-report

Written by Customer Service on October 25, 2019. Posted in Earnings Releases And Operating Results.

Period July – September·Order bookings increased by 2 percent to MSEK 195 (191).·Revenue decreased by 1 percent to MSEK 171 (172).·Operating profit amounted to MSEK 19.3 (19.1).·Profit for the period amounted to MSEK 14.0 (13.8).·Earnings per share amounted to SEK 1.23 (1.21).Period January – September·Order bookings increased by 1 percent and amounted to MSEK 561 (556).·Revenue increased by 4 percent to MSEK 545 (526).·Revenue adjusted for currency effects amounted to MSEK 521 (526), i.e. an underlying organic decrease of 1 percent.·Operating profit amounted to MSEK 54.6 (59.8).·Profit for the period amounted to MSEK 40.1 (44.4).·Earnings per share amounted to SEK 3.52 (3.90).·Cash flow from operating activities amounted to MSEK 52.2 (33.6).Significant events during the quarter·Decreased sales to a few customers with low...

Nilörngruppen AB: Delårsrapport Q3

Written by Customer Service on October 25, 2019. Posted in Earnings Releases And Operating Results.

Perioden juli – september·Orderingången ökade med 2 procent till 195 (191) MSEK·Omsättningen minskade med 1 procent till 171 (172) MSEK·Rörelseresultatet uppgick till 19,3 (19,1) MSEK·Periodens resultat uppgick till 14,0 (13,8) MSEK·Resultatet per aktie uppgick till 1,23 (1,21) SEKPerioden januari – september·Orderingången ökade med 1 procent till 561 (556) MSEK·Omsättningen i SEK ökade med 4 procent till 545 (526) MSEK·Omsättningen justerat för valutaeffekter uppgick till 521 (526) MSEK, dvs en underliggande organisk minskning om 1 procent·Rörelseresultatet uppgick till 54,6 (59,8) MSEK·Periodens resultat uppgick till 40,1 (44,4) MSEK·Resultatet per aktie uppgick till 3,52 (3,90) SEK·Kassaflödet från den löpande verksamheten uppgick till 52,2 (33,6) MSEKVäsentliga händelser under kvartalet·Minskad omsättning till ett par...

Outotec’s interim report January-September 2019

Written by Customer Service on October 25, 2019. Posted in Earnings Releases And Operating Results.

OUTOTEC OYJ INTERIM REPORT OCTOBER 25, 2019 AT 9:00 AMOutotec’s interim report January-September 2019Strong growth in order intake and service sales, significant improvement in profitability“The market for minerals and metals processing technologies continued to be positive during the reporting period. Our order intake increased by 26% from last year in the reporting period and by 69% in the third quarter. In the second and third quarter, we booked two large greenfield orders related to both minerals processing and metals refining. Brownfield investments remained at the previous year’s level. Our service business continued to develop well during the reporting period with order intake increasing 15% from last year and 20% during third quarter.Sales were slightly lower for the reporting period and for the third quarter remained on...

Outotecin tammi-syyskuun 2019 osavuosikatsaus

Written by Customer Service on October 25, 2019. Posted in Earnings Releases And Operating Results.

OUTOTEC OYJ OSAVUOSIKATSAUS 25.10.2019 KLO 9.00Outotecin tammi-syyskuun 2019 osavuosikatsausTilauskertymä ja palvelujen myynti kasvoivat vahvasti, kannattavuus parani merkittävästi”Rikastus- ja metallinjalostusteknologioiden markkinailmapiiri jatkui katsauskaudella suotuisana. Tilauskertymä kasvoi raportointikaudella 26 % ja kolmannella vuosineljänneksellä 69 % vuoden takaisesta. Toisen ja kolmannen vuosineljänneksen tilauskertymään kirjattiin kaksi suurta uusinvestointitilausta rikastamo- ja metallinjalostuslaitoksista. Investoinnit olemassa oleviin laitoksiin pysyivät edellisvuoden tasolla. Palveluliiketoiminta kehittyi edelleen hyvin; tilauskertymä kasvoi 15 % vuoden takaisesta ja 20 % kolmannella vuosineljänneksellä.Liikevaihto laski raportointikaudella hieman vertailukaudesta. Kolmannen vuosineljänneksen liikevaihto pysyi vertailukauden...

Interim Report – 6 months 1 April-30 September 2019

Written by Customer Service on October 25, 2019. Posted in Earnings Releases And Operating Results.

Second quarter (1 July-30 September 2019)Revenue increased by 5 percent to MSEK 1,432 (1,369).EBITA increased to MSEK 80 (72), corresponding to an EBITA margin of 5.6 percent (5.3).Operating profit rose by 10 percent to MSEK 75 (68), corresponding to an operating margin of 5.2 percent (5.0).Profit after financial items increased to MSEK 71 (66).Net profit increased by 8 percent to MSEK 56 (52).Earnings per share for the most recent 12-month period totalled SEK 8.25, compared with SEK 8.20 for the 2018/19 financial year.Cash flow from operating activities for the most recent 12-month period amounted to MSEK 424.The return on equity for the most recent 12-month period was 18 percent (18) and the return on working capital (P/WC) was 25 percent (24).The operational net loan liability amounted to MSEK 349 (419) and the equity/assets ratio...

Delårsrapport – 6 månader 1 april-30 september 2019

Written by Customer Service on October 25, 2019. Posted in Earnings Releases And Operating Results.

Andra kvartalet (1 juli-30 september 2019)Nettoomsättningen ökade med 5 procent till 1 432 MSEK (1 369).EBITA ökade till 80 MSEK (72), motsvarande en EBITA-marginal om 5,6 procent (5,3).Rörelseresultatet ökade med 10 procent till 75 MSEK (68), motsvarande en rörelsemarginal om 5,2 procent (5,0).Resultatet efter finansiella poster ökade till 71 MSEK (66).Resultatet efter skatt ökade med 8 procent till 56 MSEK (52).Resultatet per aktie för den senaste 12-månadersperioden uppgick till 8,25 SEK, att jämföra med 8,20 SEK för räkenskapsåret 2018/19.Kassaflödet från den löpande verksamheten för den senaste 12-månadersperioden uppgick till 424 MSEK.Avkastningen på eget kapital för den senaste 12-månadersperioden uppgick till 18 procent (18) och avkastningen på rörelsekapitalet (R/RK) till 25 procent (24).Den operativa nettolåneskulden uppgick...

Day: October 25, 2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals